Sign in
4

Changes in Ownership

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-23-022480

EVP, Corp Strategy & Develop sold 700 shares at $216.52 ($151,564)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
LaPlume Joseph W EVP, Corp Strategy & Develop 2023-08-10 Sale −700 $216.52 $151,564 24,983 D: show line 1 in the form
Open-market sales · 700 sh · avg $216.52 · $151,564
Loading xslF345X05/form4.xml…